Osteoporosis: Common Questions and Answers

Area of Science:

• Bone health and osteoporosis management.
• Geriatric medicine and public health.

Background:

• Osteoporosis affects over 10% of adults over 50, with projections indicating a rise by 2030.
• Osteoporotic fractures, particularly hip fractures, lead to significant morbidity, mortality, and reduced quality of life.

Purpose of the Study:

• To outline current recommendations for osteoporosis screening in men and women.
• To define diagnostic criteria for osteoporosis.
• To discuss lifestyle modifications and therapeutic strategies for managing osteoporosis and reducing fracture risk.

Main Methods:

• Review of current screening guidelines from organizations like the Bone Health and Osteoporosis Foundation and the U.S. Preventive Services Task Force.
• Definition of osteoporosis diagnosis based on dual energy x-ray absorptiometry (DXA) T-scores and fragility fractures.
• Discussion of evidence-based lifestyle interventions and pharmacological treatments.

Main Results:

• Screening is advised for women aged 65 and older, postmenopausal women with risk factors, and men aged 70 and older with risk factors.
• Osteoporosis is diagnosed with a T-score of -2.5 or lower or a history of fragility fracture.
• Lifestyle counseling (exercise, smoking cessation, alcohol moderation, calcium/vitamin D) is crucial. Treatment selection depends on fracture risk, efficacy, and safety, with antiresorptive and anabolic agents available.

Conclusions:

• Osteoporosis poses a significant public health challenge, necessitating timely screening and diagnosis.
• A multi-faceted approach including lifestyle modifications and appropriate pharmacotherapy is essential for effective osteoporosis management and fracture prevention.
• Personalized treatment strategies, considering individual fracture risk, are key to optimizing patient outcomes.